Biochemistry, Molecular biology, Internal medicine, Cancer research and Stereochemistry are his primary areas of study. As part of his studies on Biochemistry, Young Ho Kim frequently links adjacent subjects like Nitric oxide. His Molecular biology study combines topics from a wide range of disciplines, such as Cell culture, Gene expression, Gene, T cell and Cell biology.
His Internal medicine research focuses on subjects like Gastroenterology, which are linked to Colonoscopy. His biological study spans a wide range of topics, including Carcinogenesis, Cancer, Breast cancer, Oncogene and Lung cancer. His study looks at the intersection of Stereochemistry and topics like Pharmacognosy with Sesquiterpene.
Young Ho Kim mostly deals with Biochemistry, Internal medicine, Stereochemistry, Molecular biology and Traditional medicine. Young Ho Kim is interested in Enzyme, which is a field of Biochemistry. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology and Oncology.
His primary area of study in Stereochemistry is in the field of Glycoside. His research on Molecular biology frequently connects to adjacent areas such as Apoptosis.
Young Ho Kim mainly focuses on Biochemistry, Internal medicine, Traditional medicine, Pharmacology and Stereochemistry. His is involved in several facets of Biochemistry study, as is seen by his studies on Enzyme and Tyrosinase. Internal medicine is frequently linked to Gastroenterology in his study.
His study ties his expertise on Anti-inflammatory together with the subject of Traditional medicine. Pharmacology is often connected to In vivo in his work. His Stereochemistry study frequently involves adjacent topics like Epoxide hydrolase 2.
His primary areas of study are Biochemistry, Traditional medicine, Pharmacology, Stereochemistry and Enzyme. His Biochemistry study focuses mostly on Tyrosinase, IC50, In vitro, Phosphorylation and Nitric oxide synthase. His Traditional medicine study integrates concerns from other disciplines, such as Anti-inflammatory and Botany.
Young Ho Kim interconnects Inflammation, TRPV1 and In vivo in the investigation of issues within Pharmacology. His research integrates issues of Epoxide hydrolase 2 and Hydrogen bond in his study of Stereochemistry. His studies deal with areas such as Molecular simulation, In silico and Inhibitory postsynaptic potential as well as Enzyme.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Evolutionary and biomedical insights from the rhesus macaque genome
Richard A. Gibbs;Jeffrey Rogers.
Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids
Chang Ji Zheng;Jung-Sung Yoo;Tae-Gyu Lee;Hee-Young Cho.
FEBS Letters (2005)
Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins
Ruben D. Ramirez;Shelley Sheridan;Luc Girard;Mitsuo Sato.
Cancer Research (2004)
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer
Anna Bergamaschi;Young H. Kim;Pei Wang;Pei Wang;Therese Sørlie.
Genes, Chromosomes and Cancer (2006)
Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt
Ju Hyung Woo;Young Ho Kim;Yun Jung Choi;Dae Gon Kim.
Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study.
Suk-Kyun Yang;Sungcheol Yun;Jin-Ho Kim;Joon Yong Park.
Inflammatory Bowel Diseases (2003)
Anterior Openbite and its Treatment with Multiloop Edgewise Archwire
Young H. Kim.
Angle Orthodontist (2009)
Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer
Joseph Amann;Shailaja Kalyankrishna;Pierre P. Massion;Joyce E. Ohm.
Cancer Research (2005)
Cold shock induces a major ribosomal-associated protein that unwinds double-stranded RNA in Escherichia coli.
Pamela G. Jones;Masanori Mitta;Youngho Kim;Weining Jiang.
Proceedings of the National Academy of Sciences of the United States of America (1996)
Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials
Thomas H. Marsilje;Wei Pei;Bei Chen;Wenshuo Lu.
Journal of Medicinal Chemistry (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: